You are searching for: hsa04071

---

T23673 Target Info	Target Name	Proto-oncogene c-RAF (c-RAF)
	Target type	Clinical trial Target
	Disease	Autoimmune diabetes; Inflammatory bowel disease;
	Drugs	Semapimod	Drug Info

T40491 Target Info	Target Name	Serine/threonine PP2A-alpha (PPP2CA)
	Target type	Clinical trial Target
	Disease	Molluscum contagiosum infection; Astrocytoma;
	Drugs	VP-102	Drug Info

T31989 Target Info	Target Name	Sphingosine kinase 2 (SPHK2)
	Target type	Clinical trial Target
	Disease	Advanced solid tumour; Hepatocellular carcinoma;
	Drugs	ABC294640	Drug Info

T86552 Target Info	Target Name	Tumor necrosis factor receptor type I (TNF-R1)
	Target type	Clinical trial Target
	Disease	Malignant glioma; Recurrent glioblastoma;
	Drugs	VB-111	Drug Info

T40192 Target Info	Target Name	DNA-binding factor KBF1 (p105)
	Target type	Clinical trial Target
	Disease	Duchenne dystrophy; Solid tumour/cancer;
	Drugs	P54	Drug Info

T48598 Target Info	Target Name	GTPase KRas (KRAS)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	AZD4785	Drug Info

T50089 Target Info	Target Name	Sphingosine-1-phosphate receptor 5 (S1PR5)
	Target type	Clinical trial Target
	Disease	Multiple sclerosis;
	Drugs	ASP-4058	Drug Info

T30731 Target Info	Target Name	Kininogen (KNG1)
	Target type	Clinical trial Target
	Disease	Hereditary angioedema;
	Drugs	Avoralstat	Drug Info

T10383 Target Info	Target Name	Phospholipase D2 (PLD2)
	Target type	Clinical trial Target
	Disease	Coagulation defect;
	Drugs	VU0364739	Drug Info

T03046 Target Info	Target Name	Mutated KRAS (mKRAS)
	Target type	Clinical trial Target
	Disease	Pancreatic cancer;
	Drugs	GI-4000 + gemcitabine	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.